Provided by Tiger Trade Technology Pte. Ltd.

Vanda Pharmaceuticals

7.00
-0.1200-1.69%
Volume:2.79M
Turnover:19.53M
Market Cap:413.68M
PE:-1.87
High:7.28
Open:7.20
Low:6.73
Close:7.12
52wk High:9.94
52wk Low:3.81
Shares:59.10M
Float Shares:49.48M
Volume Ratio:0.82
T/O Rate:5.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7413
EPS(LYR):-3.7413
ROE:-50.93%
ROA:-16.50%
PB:1.26
PE(LYR):-1.87

Loading ...

Feb 16, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 28, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2023

Major Issues Report

Form 8-K - Current report
Jul 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 09, 2023

Major Issues Report

Form 8-K - Current report